| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |